Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: Follow-up of 46 adult patients with units shipped from a single cord blood bank

Transfusion

Volumn 43, Issue 9, 2003, Pages 1285-1295

  Nagamura Inoue, Tokiko ^b   Shioya, Mika ^b   Sugo, Michiko ^b   Cui, Yan ^b   Takahashi, Atsuko ^b   Tomita, Satomi ^b   Zheng, Yizhou ^b   Takada, Kei ^b   Kodo, Hideki ^b   Asano, Shigetaka ^b   Takahashi, Tsuneo A ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW CELL; BONE MARROW HYPOPLASIA; CELL TRANSPLANTATION; CLINICAL ARTICLE; CORD BLOOD TRANSPLANTATION; FEMALE; HUMAN; JAPAN; MALE; NEUTROPHIL; OSMOTIC STRESS; THAWING; THROMBOCYTE; UMBILICAL CORD BLOOD;

EID: 0041333158     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00486.x     Document Type: Article

References (34)

1. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-66.
2. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 1989;86:3828-32.
3. Gluckman E. Recent trends in allogeneic bone marrow transplantation. Clin Transpl 1989:123-8.
4. Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood 1993;81:1679-90.
5. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
6. Gluckman E. Hematopoietic stem-cell transplants using umbilical-cord blood. N Engl J Med 2001;344:1860-1.
7. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001;97:2962-71.
8. Gluckman E, Rocha V, Chevret S. Results of unrelated umbilical cord blood hematopoietic stem cell transplantation. Rev Clin Exp Hematol 2001;5:87-99.
9. Cairo SM, Wagner EJ. Placental and/or umbilical cord blood. An alternative source of hematopoietic stem cells for transplantation. Blood 1997;90:4665-78.
10. Rocha V, Wagner JE Jr, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000;342:1846-54.
11. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 1995;92:10119-22.
12. Rubinstein P, Taylor PE, Scaradavou A, et al. Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program. Blood Cells 1994;20:587-600.
13. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997;337:373-81.
14. Ohnuma K, Isoyama K, Ikuta K, et al. Cord blood transplantation from HLA-mismatched unrelated donors as a treatment for children with haematological malignancies. Br J Haematol 2001;112:981-7.
15. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611-8.
16. Migliaccio AR, Adamson JW, Stevens CE, et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000;96:2717-22.
17. Parks DR, Bryan VM, Oi VT, Herzenberg LA. Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter. Proc Natl Acad Sci U S A 1979;76:1962-6.
18. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18:295-304.
19. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
20. Ooi J, Iseki T, Nagayama H, et al. Unrelated cord blood transplantation for adult patients with myelodysplastic syndrome-related secondary acute myeloid leukaemia. Br J Haematol 2001;114:834-6.
21. Iseki T, Ooi J, Tomonari A, et al. Unrelated cord blood transplantation in adult patients with hematological malignancy. Blood 2001;98:665a.
22. Ooi J, Iseki T, Takahashi S, et al. Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood 2003;101:4711-3.
23. Albanell J, Baselga J. Systemic therapy emergencies. Semin Oncol 2000;27:347-61.
24. Chaloupka JC, Huddle DC, Alderman J, et al. A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. AJNR Am J Neuroradiol 1999;20:401-10.
25. Eberhardt R, Zwingers T, Hofmann R. [DMSO in patients with active gonarthrosis. A double-blind placebo controlled phase III study]. Fortschr Med 1995;113:446-50.
26. Scherbel AL. The effect of percutaneous dimethyl sulfoxide on cutaneous manifestations of systemic sclerosis. Ann N Y Acad Sci 1983;411:120-30.
27. Saito K, Sasayama N, Sato T, Takahashi AT. Effect of washing procedures on cord blood transplantation: engraftment of human CD45+ cells in NOD/SCID mice transplanted with cord blood stem cells with or without washing out of DMSO after cryopreservation. Blood 2000;96:379a.
28. Takahashi T, Hirsh A, Erbe E, Williams RJ. Mechanism of cryoprotection by extracellular polymeric solutes. Biophys J 1988;54:509-18.
29. Williams RJ. The surface activity of PVP and other polymers and their antihemolytic activity. Cryobiology 1983;20:521-6.
30. Woods EJ, Liu J, Derrow CW, et al. Osmometric and permeability characteristics of human placental /umbilical cord blood CD34+ cells and their application to cryopreservation. J Hematother Stem Cell Res 2000;9:161-73.
31. Ohnuma K, Isoyama K, Ikuta K, et al. The influence of HLA genotyping compatibility on clinical outcome after cord blood transplantation from unrelated donors. J Hematother Stem Cell Res 2000;9:541-50.
32. Nishihira H, Kato K, Isoyama K, et al. The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis. Br J Haematol 2003;120:516-22.
33. Locatelli F, Bruno B, Zecca M, et al. Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial. Blood 2000;96:1690-7.
34. Locatelli F, Rocha V, Reed W, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003;101:2137-43.